Humanwell Healthcare Group Co

Humanwell Healthcare Group Co EBIT Margin

The EBIT Margin (Operating Margin) of Humanwell Healthcare Group Co (600079.SS) as of Oct 30, 2026 is 15.96 %. In the previous year, EBIT Margin (Operating Margin) was 9.92 % — a change of 60.98% (higher).

EBIT Margin

15.96 %

YoY

60.98%

Last updated:

EBIT Margin (Operating Margin) of Humanwell Healthcare Group Co is 2025 15.96 % . EBIT Margin (Operating Margin) of Humanwell Healthcare Group Co was 2024 9.92 % . It decreases by 60.98% higher compared to the previous year.

Humanwell Healthcare Group Co's operating (EBIT) margin stands at 16.0%, up from 10.9% several years earlier.

The Humanwell Healthcare Group Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
9.66 CNY
Jan 1, 2019
8.44 CNY
Jan 1, 2020
10.12 CNY
Jan 1, 2021
10.94 CNY
Jan 1, 2022
15.74 CNY
Jan 1, 2023
14.06 CNY
Jan 1, 2024
9.92 CNY
Jan 1, 2025
15.96 CNY
The Humanwell Healthcare Group Co EBIT Margin history
YEAREBIT MarginYoY
15.96 %+60.98%
9.92 %-29.46%
14.06 %-10.70%
15.74 %+43.82%
10.94 %+8.20%
10.12 %+19.87%
8.44 %-12.61%
9.66 %-50.76%
19.61 %+80.43%
10.87 %+11.02%
9.79 %-13.16%
11.27 %+9,012.60%
0.12 %-7.90%
0.13 %-11.36%
0.15 %-10.08%
0.17 %+25.05%
0.13 %+17.24%
0.11 %-2.50%
0.12 %-34.17%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

EBIT Margin (Operating Margin) of Humanwell Healthcare Group Co is 15.96 % in 2025.

EBIT Margin (Operating Margin) of Humanwell Healthcare Group Co changed from 9.92 % to 15.96 %, representing a 60.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Humanwell Healthcare Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Humanwell Healthcare Group Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Humanwell Healthcare Group Co